- Home
- FLGT vs NPFD Comparison
FLGT vs NPFD Comparison
Compare FLGT & NPFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGT
- NPFD
- Stock Information
- Founded
- FLGT 2011
- NPFD 2021
- Country
- FLGT United States
- NPFD United States
- Employees
- FLGT N/A
- NPFD N/A
- Industry
- FLGT Medical Specialities
- NPFD Trusts Except Educational Religious and Charitable
- Sector
- FLGT Health Care
- NPFD Finance
- Exchange
- FLGT Nasdaq
- NPFD Nasdaq
- Market Cap
- FLGT 508.7M
- NPFD 453.8M
- IPO Year
- FLGT 2016
- NPFD N/A
- Fundamental
- Price
- FLGT $16.46
- NPFD $19.10
- Analyst Decision
- FLGT Hold
- NPFD
- Analyst Count
- FLGT 1
- NPFD 0
- Target Price
- FLGT $22.00
- NPFD N/A
- AVG Volume (30 Days)
- FLGT 225.7K
- NPFD 64.7K
- Earning Date
- FLGT 02-28-2025
- NPFD 01-01-0001
- Dividend Yield
- FLGT N/A
- NPFD 6.28%
- EPS Growth
- FLGT N/A
- NPFD N/A
- EPS
- FLGT N/A
- NPFD N/A
- Revenue
- FLGT $277,761,000.00
- NPFD N/A
- Revenue This Year
- FLGT N/A
- NPFD N/A
- Revenue Next Year
- FLGT $16.00
- NPFD N/A
- P/E Ratio
- FLGT N/A
- NPFD N/A
- Revenue Growth
- FLGT N/A
- NPFD N/A
- 52 Week Low
- FLGT $15.99
- NPFD $14.50
- 52 Week High
- FLGT $25.50
- NPFD $18.07
- Technical
- Relative Strength Index (RSI)
- FLGT 42.71
- NPFD 53.51
- Support Level
- FLGT $16.47
- NPFD $19.05
- Resistance Level
- FLGT $17.39
- NPFD $19.22
- Average True Range (ATR)
- FLGT 0.54
- NPFD 0.15
- MACD
- FLGT 0.10
- NPFD -0.01
- Stochastic Oscillator
- FLGT 33.57
- NPFD 29.55
About FLGT Fulgent Genetics Inc.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
About NPFD Nuveen Variable Rate Preferred & Income Fund
Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.